SOD2
药理学
活性氧
线粒体
线粒体ROS
氧化应激
医学
心肌保护
SIRT3
线粒体内膜
细胞凋亡
平衡
苯肾上腺素
化学
肌肉肥大
信号转导
细胞生物学
内科学
细胞内
抗氧化剂
内分泌学
基因沉默
生物
超氧化物
NADPH氧化酶
生物能学
作者
Tsendsuren Tungalag,Dong Kwon Yang
摘要
Butein (3,4,2',4'-tetrahydroxychalcone) is a bioactive chalcone with antioxidant, anti-inflammatory, and cytoprotective properties. However, its effects on pathological cardiac hypertrophy and the underlying molecular mechanisms remain unclear. In this study, neonatal rat ventricular cardiomyocytes stimulated with phenylephrine and mouse models of transverse aortic constriction (TAC) at 2 and 8 weeks were used to investigate the protective effects of butein in vitro and in vivo. Butein markedly reduced cardiomyocyte hypertrophy, decreased intracellular and mitochondrial reactive oxygen species, preserved mitochondrial membrane potential, and restored mitochondrial bioenergetic status. Mechanistically, butein enhanced nuclear accumulation of Nrf2, restored antioxidant gene expression, and reactivated AMPK-Sirt3-FoxO3a signaling while reversing SOD2 hyperacetylation. In vivo, butein suppressed cardiac hypertrophy during the early compensated stage (2week TAC) and alleviated cardiac remodeling, fibrosis, and functional deterioration during the advanced pathological stage (8-week TAC). Notably, genetic silencing of Nrf2 or Sirt3 and pharmacological inhibition of Nrf2 attenuated the protective effects of butein, supporting the involvement of Nrf2-Sirt3 signaling both in vitro and in vivo. Collectively, these findings demonstrate that butein mitigates pathological cardiac hypertrophy by restoring redox and mitochondrial homeostasis through coordinated Nrf2-Sirt3 signaling.
科研通智能强力驱动
Strongly Powered by AbleSci AI